Form 8-K Voyager Therapeutics, For: Mar 17
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Voyager Therapeutics (VYGR) Misses Q4 EPS by 12c
March 17, 2016 8:25 AM EDTVoyager Therapeutics (NASDAQ: VYGR) reported Q4 EPS of ($0.67), $0.12 worse than the analyst estimate of ($0.55). Revenue for the quarter came in at $4.94 million versus the consensus estimate of $3.73 million.
Cash, cash equivalents and marketable securities as of December 31, 2015 were approximately $224 million, compared to $161 million on September... More
